TSXV: MGRO | OTCQB: MGROF | FRA: 0C0

NexusBioAg R&D Partnership

WHAT:

  • Exclusive field trials on canola and pulse crops diseases (TerraMG™)
  • Region: Canada
  • Exclusive marketing and distribution agreement signed

WHY:

  • Canola and pulse crops are impacted by two diseases with no effective controls (Clubroot and Aphanomyces, respectively)
  • These diseases can be easily spread
  • Estimate of over US$500 million/yr of economic loss

MARKET POTENTIAL EXAMPLE:

  • ~30 million acres/yr of Canola and Pulses
  • Market Penetration: ~8% of total acreage
  • Estimated Value Opportunity at Peak: ~US$68 million/yr

NEXT STEPS:

  • 2023 plot work continues in western Canada
  • 2023 Showcase Trial at Ag In Motion Farmer event (over 30,000 attendees)
  • 2024 large scale field permits from PMRA for NexusBioAg’s BioAg Advantage Trials (BAT)

Source: 3rd Party Ag Market Researcher, MustGrow estimates